Small molecule inhibitors of PIM1 kinase: July 2009 to February 2013 patent update

Author： Arunesh Gubbi M Shanthi Ekambaram Krishna Mudeenahally H Sooriya Kumar Jegatheesan Viswanadhan Vellarkad N

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.24, Iss.1, 2014-01, pp. : 5-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small-molecule BACE1 inhibitors: a patent literature review (2006 – 2011)

By Probst Gary Xu Ying-zi

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 511-540

Informa Healthcare

Access to resources Recommend Favorite

Small-Molecule HIV-1 Integrase Inhibitors: the 2001-2002 Update

Current Pharmaceutical Design, Vol. 9, Iss. 22, 2003-08 ,pp. : 1789-1802

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule Inhibitors of the Class 1 Receptor Tyrosine Kinase Family

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 9, 2002-09 ,pp. : 1001-1010

Bentham Science Publishers

Access to resources Recommend Favorite

Checkpoint kinase inhibitors: a patent review (2009 –– 2010)

By Lainchbury Michael Collins Ian

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 8, 2011-08 ,pp. : 1191-1210

Informa Healthcare

Access to resources Recommend Favorite

Update on lymphocyte specific kinase inhibitors: a patent survey

By Martin Matthew W Machacek Michelle R

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 11, 2010-11 ,pp. : 1573-1593

Informa Healthcare

Access to resources Recommend Favorite